Fusen Pharmaceutical Company Limited 1652.HK Stock
Fusen Pharmaceutical Company Limited Price Chart
Fusen Pharmaceutical Company Limited 1652.HK Financial and Trading Overview
| Fusen Pharmaceutical Company Limited stock price | 0.9 HKD |
| Previous Close | 1.27 HKD |
| Open | 1.25 HKD |
| Bid | 1.23 HKD x 0 |
| Ask | 1.26 HKD x 0 |
| Day's Range | 1.25 - 1.26 HKD |
| 52 Week Range | 0.89 - 2.1 HKD |
| Volume | 14K HKD |
| Avg. Volume | 189.72K HKD |
| Market Cap | 945.47M HKD |
| Beta (5Y Monthly) | 0.316337 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.05 HKD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | June 7, 2022 |
| 1y Target Est | N/A |
1652.HK Valuation Measures
| Enterprise Value | 1.06B HKD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.9226365 |
| Price/Book (mrq) | 1.5555556 |
| Enterprise Value/Revenue | 2.159 |
| Enterprise Value/EBITDA | 14.682 |
Trading Information
Fusen Pharmaceutical Company Limited Stock Price History
| Beta (5Y Monthly) | 0.316337 |
| 52-Week Change | 33.68% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.1 HKD |
| 52 Week Low | 0.89 HKD |
| 50-Day Moving Average | 1.33 HKD |
| 200-Day Moving Average | 1.22 HKD |
1652.HK Share Statistics
| Avg. Volume (3 month) | 189.72K HKD |
| Avg. Daily Volume (10-Days) | 49.9K HKD |
| Shares Outstanding | 750.37M |
| Float | 171.09M |
| Short Ratio | N/A |
| % Held by Insiders | 76.61% |
| % Held by Institutions | 0.027% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -7.036% |
| Operating Margin (ttm) | 9.23% |
| Gross Margin | 45.75% |
| EBITDA Margin | 14.70% |
Management Effectiveness
| Return on Assets (ttm) | 2.19% |
| Return on Equity (ttm) | -5.45% |
Income Statement
| Revenue (ttm) | 491.76M HKD |
| Revenue Per Share (ttm) | 0.65 HKD |
| Quarterly Revenue Growth (yoy) | 90.20% |
| Gross Profit (ttm) | 225.02M HKD |
| EBITDA | 72.33M HKD |
| Net Income Avi to Common (ttm) | -34605000 HKD |
| Diluted EPS (ttm) | -0.05 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 132.7M HKD |
| Total Cash Per Share (mrq) | 0.18 HKD |
| Total Debt (mrq) | 232.99M HKD |
| Total Debt/Equity (mrq) | 38.01 HKD |
| Current Ratio (mrq) | 0.85 |
| Book Value Per Share (mrq) | 0.81 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 110.49M HKD |
| Levered Free Cash Flow (ttm) | 150.87M HKD |
Profile of Fusen Pharmaceutical Company Limited
| Country | Hong Kong |
| State | N/A |
| City | Nanyang |
| Address | Urban Industrial Zone |
| ZIP | N/A |
| Phone | N/A |
| Website | https://www.fusenyy.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 1159 |
Fusen Pharmaceutical Company Limited, an investment holding company, manufactures and sells pharmaceutical products in the People's Republic of China. The company's product portfolio includes Shuanghuanglian-based cold medicines comprising Shuanghuanglian oral solutions and Shuanghuanglian injections; and flunarizine hydrochloride capsules and compound ferrous sulfate granules, as well as Yuanhu Zhitong oral solutions, Ganweikang tablets, and Yixinkang tablets. It also researches, develops, produces, and sells various proprietary Chinese medicines and western medicine products for the treatment of cold and fever, cardiovascular diseases, and anemia. In addition, the company offers business management and consulting services. Fusen Pharmaceutical Company Limited was founded in 2003 and is headquartered in Nanyang, China.
Q&A For Fusen Pharmaceutical Company Limited Stock
What is a current 1652.HK stock price?
Fusen Pharmaceutical Company Limited 1652.HK stock price today per share is 0.9 HKD.
How to purchase Fusen Pharmaceutical Company Limited stock?
You can buy 1652.HK shares on the HKSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Fusen Pharmaceutical Company Limited?
The stock symbol or ticker of Fusen Pharmaceutical Company Limited is 1652.HK.
Which industry does the Fusen Pharmaceutical Company Limited company belong to?
The Fusen Pharmaceutical Company Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does Fusen Pharmaceutical Company Limited have in circulation?
The max supply of Fusen Pharmaceutical Company Limited shares is 740.62M.
What is Fusen Pharmaceutical Company Limited Price to Earnings Ratio (PE Ratio)?
Fusen Pharmaceutical Company Limited PE Ratio is now.
What was Fusen Pharmaceutical Company Limited earnings per share over the trailing 12 months (TTM)?
Fusen Pharmaceutical Company Limited EPS is -0.05 HKD over the trailing 12 months.
Which sector does the Fusen Pharmaceutical Company Limited company belong to?
The Fusen Pharmaceutical Company Limited sector is Healthcare.